CSRC pledges market stability as state funds deploy 60 billion yuan

China's securities regulator pledged to stabilize the A-share market as state-owned platforms deployed more than 60 billion yuan in stock purchases, the strongest coordinated intervention since the September 2024 stimulus blitz.

"The broad mass of investors are the foundation of the market and the most important participant group in the capital market," Wu Qing, chairman of the China Securities Regulatory Commission, told eight investor representatives at a symposium in Beijing on July 20.

The CSRC symposium came a day after China Reform Holdings Corp. and China Chengtong Holdings Group announced roughly 60 billion yuan of ETF and equity purchases on July 19. Five insurance firms and multiple state-owned enterprises followed on July 20 with buyback and dividend pledges, while five central SOE-controlled listed companies disclosed asset-injection plans. The CSI 300 index has fallen sharply this month, with aggregate losses approaching 10 trillion yuan, according to market data.

The intervention signals Beijing's determination to defend the 3,800-point level on the CSI 300, a threshold that has historically triggered state-buying programs. With the National 9-Point reform framework already in place, the question for investors is whether this round of support can sustain a recovery — or merely delay further declines as overseas risk factors persist.

Investor Demands Converge on Five Priorities

The symposium's investor representatives — drawn from large, medium, small and retail categories — focused their recommendations on five areas: strengthening counter-cyclical adjustments between primary and secondary markets, channeling more long-term capital into equities, regulating quantitative trading and AI applications in markets, pushing listed companies to increase dividend payouts, and raising the cost of securities violations. These demands align closely with the National 9-Point reform agenda introduced in April 2024, which has already tightened IPO standards and expanded delisting mechanisms.

Wu Qing said the CSRC would pursue "integrated advancement of risk prevention, strengthened regulation, and high-quality development" — language that echoes the commission's post-September 2024 playbook. The last time the CSRC deployed similar rhetoric and coordinated state buying was in early 2025, when the CSI 300 rebounded 12 percent over the following six weeks before renewed tariff concerns erased those gains.

State Capital as a Signaling Mechanism

The 60 billion yuan deployed by China Reform Holdings and China Chengtong represents a fraction of the roughly 3 trillion yuan in assets under management held by China's two largest state-owned capital operating platforms. But the timing — coinciding with the CSRC symposium — amplifies the signal. Five insurance companies, including China Life Insurance and PICC, separately announced stock purchases on July 20, adding to the buying pressure.

The coordinated intervention mirrors the playbook used during the February 2024 market rout, when state funds purchased an estimated 410 billion yuan of equities and ETFs over three months, according to estimates by China International Capital Corp. That campaign stabilized the CSI 300 through mid-2024 but failed to prevent a renewed selloff when U.S. tariff escalations resumed in late 2024.

For global investors watching China's capital markets, the key metric to monitor is whether the buying extends beyond state platforms to genuine institutional inflows. The symposium's call for more long-term capital — including pension funds and insurance allocations — suggests the CSRC recognizes that state buying alone cannot sustain a durable recovery. The next test will come with the July 31 Politburo meeting, where Beijing is expected to outline additional stimulus measures for the second half of 2026.

This article is for informational purposes only and does not constitute investment advice.